期刊文献+

252 Cf中子腔内照射结合挡铅与不挡铅外照射治疗宫颈癌的配对观察 被引量:1

Paired observation of californium-252 neutron intraluminal brachytherapy combined with external-beam radiotherapy with and without lead shielding for cervical cancer
原文传递
导出
摘要 目的:比较252 Cf中子腔内照射结合挡铅盆腔对穿野和不挡铅箱式四野外照射治疗宫颈癌的治疗结果。方法2004—2007年本院收治的Ⅱa—Ⅲb 期的宫颈鳞癌患者,按照临床分期、年龄、肿瘤大小、贫血程度为配对条件,共筛选出26对(52例)研究对象,分为挡铅盆腔对穿野组(挡铅组)和不挡铅箱式四野组(不挡铅组)。两组患者外照射期间穿插252 Cf中子后装治疗。 Kaplan.Meier法计算5年LC、OS、DFS 并 Logrank 检验差异,晚期并发症发生率差异行 McNemar 法检验。结果挡铅、不挡铅组5年LC 率分别为85%、81%(P=0.014),OS 率分别为89%、73%(P=0.013),DFS 率分别为89%、73%(P=0.013),晚期并发症发生率分别为12%、23%(P=0.008)。结论腔内照射结合外照射治疗宫颈癌时无论采取对穿野还是箱式四野,后程前后野中央均应挡铅。 Objective To compare the efficacy between californium.252 ( 252 Cf ) neutron intraluminal brachytherapy combined with external.beam radiotherapy with lead.shielding pelvic parallel opposing field technique and non.lead.shielding four.field box technique for cervical cancer. Methods A total of 52 patients with stage Ⅱa.Ⅲb cervical squamous cell carcinoma who were admitted to our hospital from 2004 to 2007 were enrolled as subjects and paired by clinical stage, age, tumor size, and degree of anemia. The 26 pairs of patients were divided into lead.shielding pelvic parallel opposing field group (lead.shielding group) and non.lead.shielding four.field box group (non.lead.shielding group). For all patients in both groups, 252 Cf neutron brachytherapy was added in external.beam radiotherapy. The local control (LC), overall survival (OS), and disease.free survival (DFS) rates were calculated using the Kaplan.Meier method and analyzed using the log.rank test. The difference in the incidence of late complications was analyzed using the McNemar method. Results There were significant differences in 5.year LC, OS, and DFS rates between the lead.shielding group and the non.lead.shielding group (85% vs. 81%, P= 0. 014;89% vs. 73%, P=0. 013; 89% vs. 73%, P= 0. 013 ). There was also significant difference in the incidence of late complications between the lead.shielding group and the non.lead.shielding group ( 12% vs. 23%, P=0. 008). Conclusions When intraluminal brachytherapy combined with external.beam radiotherapy is used to treat cervical cancer, the centers of the front and back fields should be shielded by lead, regardless of whether the parallel opposing field technique or the four.field box technique is used.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2015年第4期400-403,共4页 Chinese Journal of Radiation Oncology
关键词 宫颈肿瘤/ 放射疗法 放射疗法 外照射 放射疗法 252-锎中子 挡铅 Cervical neoplasms/ radiotherapy Radiotherapy,external beam radiation Radiotherapy,252 Cf neutron Lead shielding
  • 相关文献

参考文献9

  • 1Monk B J, Tewari KS, Koh WJ. Muhimodality therapy for locally advanced cervical carcinoma: state of the art and future directions [J]. J Clin Oncol,2007,25(20) :2952-2965.
  • 2Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of de- finitive intensity-modulated radiation therapy with fluorodeoxyglu- cose-positron emission tomography simulation in patients with lo- cally advanced cervical cancer [ J ]. int J Radiat Oncol Biol Phys, 2010,77(4) : 1085-1091 .DOI : 10.1016/j.ijrohp.2009.06.041.
  • 3Potter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachythera- py of locally advanced cervix cancer [ J ]. Radiother Oncol, 2007, 83(2) , 148-155.
  • 4雷新,李力,单锦露,赵克伟.^(252)锎内照射加等中心四野箱式外照射治疗宫颈癌的早期观察[J].第三军医大学学报,2006,28(6):613-614. 被引量:3
  • 5Lei X,Qian CY. Californium-252(~zCf) Brachytherapy combined with external beam radiotherapy for previously untreated cervical cancer:long-term treatment results of one institute [ J]. Int J Radi- at Oncol Biol Phys ,2011,81 (5) : 1264-1270.
  • 6Gunderson LL.Tepper JE, eds. Clinical radiation oncology[ M ]. 3rd ed. Philadelphia: Saunders Elsevier, 2012.
  • 7于金明,李宝生.调强放射治疗的临床应用现状与存在的问题[J].中华肿瘤杂志,2005,27(3):188-190. 被引量:43
  • 8李斌,安菊生,吴令英,徐英杰,戴建荣,黄曼妮,高菊珍.子宫颈癌术后盆腔不同体外照射方法的剂量学研究[J].中华放射肿瘤学杂志,2008,17(3):211-215. 被引量:40
  • 9晏俊芳,张福泉.宫颈癌腔内放疗进展[J].中华放射肿瘤学杂志,2009,18(5):382-385. 被引量:10

二级参考文献48

  • 1International Commission on Radiation Units and Measurements. Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy ( supplement to ICRU Report 50 ). Bethesda: ICRU, 1999.
  • 2McAlpine J,Schlaerth JB, Lim P, et al. Radiation fields in gynecologic oncology: correlation of soft tissue ( surgical ) to radiologic landmarks. Gynecol Oncol,2004,92:25-30.
  • 3Sedlis A,Bundy BN,Rotman MZ,et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol, 1999,73 : 177-183.
  • 4Roeske JC, Lujan A, Rotmensch J,et al. Intensity-modulated whole pelvis radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys, 2000,48 : 1613 -1621.
  • 5D'Souza W, Ahamad A, Iyer R, et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys,2005,61:1062-1070.
  • 6Ahamad A, D'Souza W, Salehpour M, et al. Intensity-modulated radiationtherapy(IMRT) after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin. Int J Radiat Oncol Biol Phys, 2005,62 : 1117- 1124.
  • 7van de Bunt L,van der Heide UA,Ketelaars M,et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys,2006, 64 : 189-196.
  • 8Heron DE, Gerszten K, Selvaraj RN, et al. Conventional 3 D conformal versus intensity-medulated radiotherapy for the adjuvant treatment of gynecologic malignancies : a comparative dosimetric study of dose-volume histograms small star,filled. Gynecol Oncol,2003, 91,39-45.
  • 9Taylor A, Rockall AG, Reznek RH, et al. Mapping pelvic lymph nodes : guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys,2005,63:1604-1612.
  • 10Kaatee RS, Olofsen M J, Verstraate MB, et al. Detection of organ movement in cervix cancer patients using a fluoroscopic electronic portal imaging device and radiopaque markers. Int J Radiat Oncol Biol Phys ,2002,54 : 576-583.

共引文献92

同被引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部